| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 8 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 8 |
| 2 | TACROLIMUS OINTMENT 0.1% | 8 |
| 3 | PREDNISOLONE | 7 |
| 4 | PREDNISOLONE ORAL | 7 |
| 5 | PREDNISOLONE ORAL SOLUTION | 7 |
| 6 | ANASTROZOLE | 6 |
| 7 | ANASTROZOLE TABLETS | 6 |
| 8 | GABAPENTIN | 6 |
| 9 | LEFLUNOMIDE | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ETOPOSIDE PHOSPHATE | 1 | 0.0006 |
| 1 | BLEOMYCIN SULFATE | 3 | 0.0003 |
| 2 | ANASTROZOLE TABLETS | 6 | 0.0003 |
| 3 | ELBASVIR AND GRAZOPREVIR | 1 | 0.0002 |
| 4 | ANASTROZOLE | 6 | 0.0002 |
| 5 | RISEDRONATE SODIUM | 3 | 0.0001 |
| 6 | TEMOZOLOMIDE | 2 | 0.0001 |
| 7 | TOFACITINIB CITRATE | 1 | 0.0001 |
| 8 | ERGOCALCIFEROL | 2 | 0.0001 |
| 9 | TACROLIMUS OINTMENT 0.1% | 8 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 1 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 1 | 0.0001 |
| 2 | Antirheumatic Agent [EPC] | 6 | 0.0001 |
| 3 | Aromatase Inhibitor [EPC] | 6 | 0.0001 |
| 4 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 5 | Topoisomerase Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Calcineurin Inhibitor Immunosuppressant [EPC] | 3 | 0.0000 |
| 7 | Hepatitis C Virus NS5A Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 2 | 0.0000 |
| 9 | Platinum-based Drug [EPC] | 3 | 0.0000 |